Behzad Aghazadeh, Ph.D.
DirectoratWhitehawk Therapeutics· In proxies 2023–2025
Behzad Aghazadeh, Ph.D. sits on 3 public boards.
Boards1
- Whitehawk TherapeuticsDirector · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Whitehawk TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -71%
- Scribe Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Immunomedics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?